Latest Breaking News On - Austrian federal office for safety - Page 2 : comparemela.com

Several People Hospitalized After Taking Suspected Fake Ozempic in Austria

The patients suffered from side effects including low blood sugar and seizures

Chelsea handlerAnia jastreboffTracy morganDolores cataniaLauren manzoSharon osbourneAustrian federal office for safetyAustrian federal officeTriple dementia riskSide effectsLow blood sugarUstrian federal office for safety in healthcarePrescription medicationUblic pharmacies

Several People Hospitalized in Austria After Taking Suspected Fake Ozempic

The drug, used to treat diabetes, has become popular as a weight loss treatment. Now, officials are warning of counterfeit versions circulating in Europe.

United kingdomHealth careDrug administrationAustrian federal office for safetyEuropean unionEuropean medicines agencyAustrian federal officeDisesases health illness medicineMedicines and healthcare products regulatory agency

They thought they were taking Ozempic — until they were hospitalized with seizures Turns out, it was fake, authorities say

The patients were suffering from seizures and low blood sugar, an indication their pens may have had insulin inside, which can be deadly.

United kingdomAustrian federal office for safetyEuropean medicines agencyEuropean unionHealth careAustrian federal officeAustrian authoritiesHealth authoritiesLow blood sugarInsulin sensitivityCounterfeit versions

Multiple System Atrophy (MSA) Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline as Leading 20+ Companies Working in the Domain |

Multiple System Atrophy (MSA) Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline as Leading 20+ Companies Working in the Domain |
medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesAmpreloxetine theravance biopharmaTheravance biopharmaShreya sumanDainippon sumitomo pharmaCorestem incIons pharmaceuticals incMarket researchKey multiple system atrophy companiesRoute of administrationChelsea therapeutics internationalSanthera pharmaceuticalsAustrian federal office for safetyIonis pharmaceuticals incBiohaven pharmaceuticals

Alterity Therapeutics (ATHE) Receives Regulatory Authorization in France and Austria to Proceed with ATH434 Phase 2 Clinical Trial

Alterity Therapeutics (ATHE) Receives Regulatory Authorization in France and Austria to Proceed with ATH434 Phase 2 Clinical Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

David stamlerAustrian federal office for safetyHealth productsMultiple system atrophyAustrian federal officeFrench national agencyChief executive officer